Adding a dimension to disease diagnostics

According to research firm Market Research Future (Pune, India), the global biomarker test market will reach $16 billion by 2022

The method could facilitate improved understanding of the mechanistic processes on molecular and cellular levels that are key to the development of diabetes

Recent discovery could be instrumental in addressing one of today's biggest public health challenges: the opioid abuse epidemic

Engineering team finds compound may halt molecular cause of often-fatal condition

In this webinar you will learn how BioSPME devices can be used to directly sample from complex biological matrices

While HPLC and mass spec make inroads into nontraditional markets, interest remains in molecular techniques that address the unique needs of  clinicians and drug developers.

Low-cost wearable electronic device collects and analyzes sweat for health monitoring

Anita Shah currently works at Doctor’s Data, Inc. (DDI), as that company’s elements technical manager.

The fluorescent sensor, derived from citric acid molecules, is highly sensitive and highly selective for chloride, the key diagnostic marker in cystic fibrosis